Fermer le menu


Member of Lyonbiopole


For more than a century, Aguettant has developped, manufactured and marketed essential drugs for hospitals. Our specialty areas are:

- anaesthesia, intensive care and emergency medicine;

- parenteral nutrition;

- the treatment of movement disorders due to Parkinson's disease;

- infusion and rinsing solutions.

With sales around €230 M and 1000 employees, the Aguettant Group develops several unique know-hows:

- ready-to-use pre-filled syringes, ideal for emergency medicine and hospital settings; 

- pen for self-injection at home;

- trace elements in injectable solutions;

- through Aguettant Diagnostics and Promise Proteomics, subsidiaries of the Aguettant Group, the development and production of in-vitro diagnostic kits in the fields of biotherapy monitoring and CBRN detection.


Strategic application domain: Human Medicine

Application market: Intensive care medicine, Neurology & Mental Health Disorders, Others

Type of activity: Diagnostics, Medical device, Therapeutics, Pharma or Biotech

Technologies: Analytical methods, diagnostic & Pronostic markers, Drug delivery device & Technologies, Genomics & Proteomics, Biochips

Created on jan. 1st, 1900 - 1000 employees



1 rue Alexander Fleming 69007 LYON



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.